Pregnancy rates and outcomes amongst women with cystic fibrosis in the UK : comparisons with the general population before and after the introduction of disease modifying treatment, 2003-17

Esan, OluwaseunSchlüter, Daniela K.Phillips, RhiannonCosgriff, RebeccaParanjothy, ShantiniWilliams, DenitzaNorman, RachelCarr, Siobhán BDuckers, JamieTaylor-Robinson, David2022-03-222022-03-222022-04Esan, O, Schlüter, D K, Phillips, R, Cosgriff, R, Paranjothy, S, Williams, D, Norman, R, Carr, S B, Duckers, J & Taylor-Robinson, D 2022, 'Pregnancy rates and outcomes amongst women with cystic fibrosis in the UK : comparisons with the general population before and after the introduction of disease modifying treatment, 2003-17', BJOG-An International Journal of Obstetrics and Gynaecology, vol. 129, no. 5, pp. 743-751. https://doi.org/10.22541/au.162182734.44469184/v1, https://doi.org/10.1111/1471-0528.169571470-0328SCOPUS: 85118552569ORCID: /0000-0002-0528-3121/work/110275483https://hdl.handle.net/2164/18284Acknowledgements We thank the UK CF Registry team and the UK CF centres and clinics for submitting data to the Registry. Special thanks to the people with cystic fibrosis and their families who have agreed for their UK CF Registry data to be used for research. Funding The study was funded by a Welsh Government Research for Patient and Public Benefit grant. The funder was not involved in the study design, data collection, data analysis, data interpretation or the writing of the report. DT-R is funded by the MRC on a Clinician Scientist Fellowship (MR/P008577/1).911139101619115engCystic fibrosisPregnancyEpidemiologycystic fibrosis transmembrane conductance regulator modulatorivacaftor epidemiologyR MedicineMedical Research Council (MRC)MR/P008577/1Supplementary DataRPregnancy rates and outcomes amongst women with cystic fibrosis in the UK : comparisons with the general population before and after the introduction of disease modifying treatment, 2003-17Journal article10.22541/au.162182734.44469184/v11295